AI Momentum Boosts Healthcare Stock, Waystar Surges 11%

Waystar Holding Corp. (NASDAQ: WAY) shares closed at $24.91 on the Nasdaq on the 15th, up 11.05% from the previous day. Trading volume reached approximately 2.86 million shares, and market capitalization rose by about $593 million (roughly KRW 770 billion) in a single day to around $4.77 billion (about KRW 6.2 trillion).

On the same day, investment research outlet Simply Wall St noted that Waystar is boosting revenue recovery efficiency with its AI-driven recoupment tool, built on more than 7.5 billion transaction records, and suggested that this AI adoption could provide near-term investment momentum.

Separately, last month Jefferies maintained its Buy rating on Waystar but slightly lowered its 12-month price target from $43 to $41.

Waystar is a healthcare technology company offering cloud-based payment software for revenue cycle management—covering billing, collections, and insurance processing—for hospitals and clinics. It leverages AI and data analytics to reduce costs and improve recovery rates.

Founded in Delaware in 2019 and listed on Nasdaq in 2024, Waystar has sustained double-digit revenue growth and high margins, further bolstered by its 2025 acquisition of Iodine Software.